Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on LinkedIn by Gianluca Franceschini, Full Professor of General Surgery and Director of the Master’s Program in Integrated Therapies for Female Oncological Pathologies at Catholic University of the Sacred Heart, adding:
“I’m honored to share highlights from today’s exceptional masterclass at Gemelli University Hospital Foundation IRCCS in Rome.
Prof. Massimo Cristofanilli, Professor of Medicine and Associate Director of Precision Medicine at Weill Cornell Medicine, New York, delivered an outstanding lecture on ‘Evolving Diagnostic and Therapeutic Approaches to HR+ Breast Cancer’ as part of the prestigious Breast Club Masterclass Series.
Prof. Cristofanilli is a global pioneer in the development and clinical application of liquid biopsy in breast cancer, and his insights into precision medicine and circulating tumor cells have been truly transformative for our understanding of HR+ breast cancer management.
I would like to express my deepest gratitude to:
- Prof. Gianluca Franceschini, Director of the Integrated Breast Unit, for his leadership and dedication to advancing breast cancer care.
- Prof. Alessandro Sgambato, Dean of the Faculty of Medicine and Surgery at Università Cattolica del Sacro Cuore, for his continuous support of academic excellence.
- Prof. Giampaolo Tortora, Director of the Comprehensive Cancer Center at Fondazione Policlinico Universitario A. Gemelli IRCCS, for fostering innovation in oncology.
These educational initiatives are invaluable for advancing knowledge and improving patient outcomes in breast cancer care.”
Quoting Gianluca Franceschini’s post:
“A great honor to host Prof. Massimo Cristofanilli at the Breast Club!
We are pleased to announce that Prof. Massimo Cristofanilli will give a lecture as part of the training activities of the ‘Breast Club – the House of Breast Specialists of the Gemelli Polyclinic’, bringing his international experience in the field of oncology and precision medicine.
With prominent roles such as:
- Professor of Medicine and Associate Director of Precision Medicine – Weill Cornell Medicine
- Scientific Director – Englander Institute of Precision Medicine
- President – Inflammatory Breast Cancer-International Consortium
- Co-Founder and Past President – International Society of Liquid Biopsy
Prof. Cristofanilli will guide us through the latest innovations in HR+ breast cancer diagnostics and therapeutic strategies, offering a unique insight into the challenges and opportunities of precision medicine.
- Tuesday 28 October 2025, 2:30 pm
- Gemelli Polyclinic, Room 715, Rome
An unmissable opportunity to update and discuss with one of the world’s leading experts in breast oncology.”
More posts featuring Armando Orlandi.
